Increased aging in primary muscle cultures of sporadic inclusion-body myositis

Neurobiology of Aging

Volumn 31, Issue 7, 2010, Pages 1205-1214

  Morosetti, Roberta ^a,b   Broccolini, Aldobrando ^a   Sancricca, Cristina ^a   Gliubizzi, Carla ^a,b   Gidaro, Teresa ^a   Tonali, Pietro A ^a,b   Ricci, Enzo ^a,b   Mirabella, Massimiliano ^a,b  

^a CATHOLIC UNIVERSITY   (Italy)

^b IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

Author keywords

Aging; Cultured muscle; Muscle regeneration; S IBM; Satellite cells

Indexed keywords

AMYLOID BETA PROTEIN[1-40]; BETA CATENIN; WNT PROTEIN;

ADULT; AGE; AGED; AGING; ARTICLE; CELL NUCLEUS; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CLONOGENESIS; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; INCLUSION BODY MYOSITIS; MUSCLE FIBER CULTURE; MUSCLE GROWTH; MUSCLE REGENERATION; MYOBLAST; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SENESCENCE; TELOMERE;

ADULT; AGED; AGED, 80 AND OVER; CELL AGING; CELL PROLIFERATION; CELLS, CULTURED; FEMALE; HUMANS; INCLUSION BODIES; MALE; MIDDLE AGED; MUSCLE, SKELETAL; MYOBLASTS; MYOSITIS, INCLUSION BODY; SATELLITE CELLS, SKELETAL MUSCLE; TELOMERE;

EID: 77952878407     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2008.08.011     Document Type: Article

References (37)

1. Askanas V., Engel W.K. A new program for investigating adult human skeletal muscle grown aneurally in tissue culture. Neurology 1975, 25:58-67.
2. Askanas V., Engel W.K. Cultured normal and genetically abnormal human muscle. Handbook of Clinical Neurology 1992, 85-116. Elsevier Science Publisher, Amsterdam, The Netherlands. L.P. Rowland, S. Di Mauro (Eds.).
3. Askanas V., Alvarez R.B., Engel W.K. beta-Amyloid precursor epitopes in muscle fibers of inclusion body myositis. Ann. Neurol. 1993, 34:551-560.
4. Askanas V., Engel W.K., Alvarez R.B. Enhanced detection of congo-red-positive amyloid deposits in muscle fibers of inclusion body myositis and brain of Alzheimer's disease using fluorescence technique. Neurology 1993, 43:1265-1267.
5. Askanas V., McFerrin J., Alvarez R.B., Baqué S., Engel W.K. Beta APP gene transfer into cultured human muscle induces inclusion-body myositis aspects. Neuroreport 1997, 8:2155-2158.
6. Askanas V., Engel W.K. Unfolding story of inclusion-body myositis and myopathies: role of misfolded proteins, amyloid-beta, cholesterol, and aging. J. Child. Neurol. 2003, 18:185-190.
7. Askanas V., Engel W.K. Inclusion-body myositis: a myodegenerative conformational disorder associated with Abeta, protein misfolding, and proteasome inhibition. Neurology 2006, 66:S39-S48.
8. Askanas V., Engel W.K. Inclusion-body myositis, a multifactorial muscle disease associated with aging: current concepts of pathogenesis. Curr. Opin. Rheumatol. 2007, 19:550-559.
9. Bigot A., Jacquemin V., Debacq-Chainiaux F., Butler-Browne G.S., Toussaint O., Furling D., Mouly V. Replicative aging down regulates the myogenic regulatory factors in human myoblasts. Biol. Cell. 2008, 100:189-199.
10. Brack A.S., Conboy M.J., Roy S., Lee M., Kuo C.J., Keller C., Rando T.A. Increased Wnt signaling during aging alters muscle stem cell fate and increases fibrosis. Science 2007, 317:807-810.
11. Brack A.S., Rando T.A. Intrinsic changes and extrinsic influences of myogenic stem cell function during aging. Stem Cell Rev. 2007, 3:226-237.
12. Broccolini A., Ricci E., Pescatori M., Papacci M., Gliubizzi C., D'Amico A., Servidei S., Tonali P., Mirabella M. Insulin-like growth factor I in inclusion-body myositis and human muscle cultures. J. Neuropathol. Exp. Neurol. 2004, 63:650-659.
13. Broccolini A., Gidaro T., Morosetti R., Gliubizzi C., Servidei T., Pescatori M., Tonali P.A., Ricci E., Mirabella M. Neprilysin participates in skeletal muscle regeneration and is accumulated in abnormal muscle fibres of inclusion body myositis. J. Neurochem. 2006, 96:777-789.
14. Carter L.S., Askanas V. Vital-freezing of human muscle cultures for storage and reculture. Muscle Nerve. 1981, 4:367-369.
15. Chakravarthy M.V., Davis B.S., Booth F.W. IGF-I restores satellite cell proliferative potential in immobilized old skeletal muscle. J. Appl. Physiol. 2000, 89:1365-1379.
16. Coggan A.R., Spina R.J., King D.S., Rogers M.A., Brown M., Nemeth P.M., Holloszy J.O. Skeletal muscle adaptations to endurance training in 60- to 70-yr-old men and women. J. Appl. Physiol. 1992, 72:1780-1786.
17. Conboy I.M., Conboy M.J., Wagers A.J., Girma E.R., Weissman I.L., Rando T.A. Rejuvenation of aged progenitor cells by exposure to a young systemic environment. Nature 2005, 433:760-764.
18. Cooper R.N., Thiesson D., Furling D., Di Santo J.P., Butler-Browne G.S., Mouly V. Extended amplification in vitro and replicative senescence: key factors implicated in the success of human myoblast transplantation. Hum. Gene Ther. 2003, 14:1169-1179.
19. Decary S., Mouly V., Hamida C.B., Sautet A., Barbet J.P., Butler-Browne G.S. Replicative potential and telomere length in human skeletal muscle: implications for satellite cell-mediated gene therapy. Hum. Gene Ther. 1997, 8:1429-1438.
20. Decary S., Hamida C.B., Mouly V., Barbet J.P., Hentati F., Butler-Browne G.S. Shorter telomeres in dystrophic muscle consistent with extensive regeneration in young children. Neuromuscul. Disord. 2000, 10:113-120.
21. Engel W.K., Askanas V. Inclusion-body myositis: clinical, diagnostic, and pathologic aspects. Neurology 2006, 66:S20-S29.
22. Finch C.E. A perspective on sporadic inclusion-body myositis: the role of aging and inflammatory processes. Neurology 2006, 66:S1-S6.
23. Hagen T., Di Daniel E., Culbert A.A., Reith A.D. Expression and characterization of GSK-3 mutants and their effect on beta-catenin phosphorylation in intact cells. J. Biol. Chem. 2002, 277:23330-23335.
24. McFerrin J., Engel W.K., Askanas V. Cultured inclusion-body myositis muscle fibers do not accumulate beta-amyloid precursor protein and can be innervated. Neurology 1999, 53:2184-2187.
25. Mouly V., Aamiri A., Bigot A., Cooper R.N., Di Donna S., Furling D., Gidaro T., Jacquemin V., Mamchaoui K., Negroni E., Périé S., Renault V., Silva-Barbosa S.D., Butler-Browne G.S. The mitotic clock in skeletal muscle regeneration, disease and cell mediated gene therapy. Acta Physiol. Scand. 2005, 184:3-15.
26. Needham M., Mastaglia F.L. Inclusion body myositis: current pathogenetic concepts and diagnostic and therapeutic approaches. Lancet Neurol. 2007, 6:620-631.
27. Nusse R. Wnt signaling in disease and in development. Cell Res. 2005, 15:28-32.
28. Périé S., Mamchaoui K., Mouly V., Blot S., Bouazza B., Thornell L.E., St Guily J.L., Butler-Browne G. Premature proliferative arrest of cricopharyngeal myoblasts in oculo-pharyngeal muscular dystrophy: therapeutic perspectives of autologous myoblast transplantation. Neuromuscul. Disord. 2006, 16:770-781.
29. Petropoulos H., Skerjanc I.S. Beta-catenin is essential and sufficient for skeletal myogenesis in P19 cells. J. Biol. Chem. 2002, 277:15393-15399.
30. Polesskaya A., Seale P., Rudnicki M.A. Wnt signaling induces the myogenic specification of resident CD45+ adult stem cells during muscle regeneration. Cell 2003, 113:841-852.
31. Prunier C., Hocevar B.A., Howe P.H. Wnt signaling: physiology and pathology. Growth Factors 2004, 22:141-150.
32. Renault V., Thornell L.E., Butler-Browne G., Mouly V. Human skeletal muscle satellite cells: aging, oxidative stress and the mitotic clock. Exp. Gerontol. 2002, 37:1229-1236.
33. Renault V., Thornell L.E., Eriksson P.O., Butler-Browne G., Mouly V. Regenerative potential of human skeletal muscle during aging. Aging Cell. 2002, 1:132-139.
34. Shavlakadze T., Grounds M. Of bears, frogs, meat, mice and men: complexity of factors affecting skeletal muscle mass and fat. Bioessays 2006, 28:994-1009.
35. Shi X., Garry D.J. Muscle stem cells in development, regeneration, and disease. Genes Dev. 2006, 20:1692-1708.
36. Taylor-Jones J.M., McGehee R.E., Rando T.A., Lecka-Czernik B., Lipschitz D.A., Peterson C.A. Activation of an adipogenic program in adult myoblasts with age. Mech. Ageing Dev. 2002, 123:649-661.
37. Wright W.E., Shay J.W. Historical claims and current interpretations of replicative aging. Nat. Biotechnol. 2002, 20:682-688.